| Code | CSB-RA011588MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to the reference antibody described in US20220177567A1, targeting IL12RB1 (Interleukin-12 Receptor Beta 1). IL12RB1 is a critical component of the heterodimeric receptor complex for both IL-12 and IL-23, two cytokines essential for Th1 and Th17 cell differentiation and function. This receptor subunit plays a pivotal role in cell-mediated immunity and inflammatory responses. Mutations in IL12RB1 are associated with Mendelian susceptibility to mycobacterial disease (MSMD), while dysregulated IL-12/IL-23 signaling has been implicated in various autoimmune conditions including inflammatory bowel disease, psoriasis, and multiple sclerosis.
The reference antibody provides a validated framework for investigating IL12RB1 expression, localization, and function in immune cells. This biosimilar antibody serves as a valuable research tool for studying cytokine receptor biology, immune cell signaling pathways, and the pathogenesis of inflammatory and immunodeficiency disorders. It enables researchers to explore therapeutic targets within the IL-12/IL-23 axis and advance understanding of receptor-mediated immune regulation.
There are currently no reviews for this product.